Executive Director, Global Clinical Bioanalytics Head
Clinical Pharmacology, Global Product Development, Pfizer Inc
Graduated from Moscow State University, after several years of research in Academia, Dr. Olga Kavetska changed her career and scientific interests and joined CRO in Montreal, Canada in 1993. For over 20 years she led regulated bioanalysis organizations in Parke-Davis, Pfizer, AbbVie. Since 2015, Dr. Kavetska is leading Global Clinical Bioanalytics organization within Clinical Pharmacology at Pfizer Global Product Development. Currently her group is responsible for overseeing clinical bioanalytics supporting Pfizer development portfolio for PK, immunogenicity and biomarkers across modalities, therapeutic areas, and phases of development, from the FIH studies to loss of exclusivity. The group is responsible for delivering assays and data enabling Pfizer clinical programs and regulatory submissions. Recently, the group remit was expanded to translational medicine, non-oncology. Dr. Kavetska has an extensive experience in drug development, regulated bioanalysis, ADME, clinical operations, global regulatory submissions, and interactions with the regulatory agencies.
Disclosure information not submitted.
Wednesday, October 19, 2022
3:15 PM – 3:30 PM ET